QuidelOrtho
QDEL
#3543
Rank
A$4.82 B
Marketcap
$71.72
Share price
4.21%
Change (1 day)
-33.93%
Change (1 year)
Quidel is an American manufacturer of diagnostics testings that can be used to diagnose infectious diseases as well as cardiovascular and metabolic diseases.

QuidelOrtho (QDEL) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : A$5.78 Billion

According to QuidelOrtho's latest financial reports the company's total liabilities are A$5.78 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

QuidelOrtho - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$5.22 B-9.39%
2022-12-31A$5.76 B733.83%
2021-12-31A$0.69 B-1.32%
2020-12-31A$0.70 B39.66%
2019-12-31A$0.50 B-7.24%
2018-12-31A$0.54 B-40.41%
2017-12-31A$0.90 B248.49%
2016-12-31A$0.26 B0.95%
2015-12-31A$0.25 B4.25%
2014-12-31A$0.24 B362.41%
2013-12-31A$53.48 M31.34%
2012-12-31A$40.72 M-55.35%
2011-12-31A$91.19 M-9.25%
2010-12-31A$0.10 B126.27%
2009-12-31A$44.41 M32.92%
2008-12-31A$33.41 M11.77%
2007-12-31A$29.89 M-0.87%
2006-12-31A$30.15 M-17.06%
2005-12-31A$36.36 M25.02%
2004-12-31A$29.08 M-21.3%
2003-12-31A$36.95 M4.96%
2002-12-31A$35.2 M-18.26%
2001-12-31A$43.07 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$0.15 B-97.37%๐Ÿ‡บ๐Ÿ‡ธ USA
A$50.21 B 768.66%๐Ÿ‡บ๐Ÿ‡ธ USA
A$81.99 B 1,318.35%๐Ÿ‡บ๐Ÿ‡ธ USA
A$61.6 M-98.93%๐Ÿ‡บ๐Ÿ‡ธ USA
A$46.87 B 710.92%๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.56 B 82.72%๐Ÿ‡บ๐Ÿ‡ธ USA